Codman Neuro Launches Family of Coils for Treatment of Brain Aneurysms

From Codman Neuro

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has introduced a new platform of embolic coils for the treatment of brain aneurysms, supported by an enhanced detachment system designed to improve microcatheter stability and provide an optimized detachment zone for coils. The family of framing, filling and finishing c...

Login to read story

Tuesday, July 14, 2015

Show last days of articles

FDA Approves Rexulti (brexpiprazole) for Depression, Schizop...

From NeurologyWire

FDA has approved Rexulti (brexpiprazole) as an adjunctive therapy for the treatment of adults with major depressive disorder (MDD) and as a treatment ...Full story

Monday, July 13, 2015

Changes in Alzheimers Biomarkers During Midlife May Predict ...

From NeurologyWire

Scientists have shown that changes in key biomarkers of Alzheimers disease during midlife may help identify those who will develop dementia years late...Full story

Friday, July 10, 2015

Teva Takes Migraine Drug Generic

From NeurologyWire

Teva Pharmaceutical Industries will be the first in the US to launch a generic form of the migraine drug Axert (almotriptan malate) tablets. The table...Full story

Study Shows Long-Term Effects of Type 2 Diabetes on the Brai...

From NeurologyWire

In a matter of two years, people with type 2 diabetes experienced reduced ability to regulate blood flow in the brain, which was associated with lower...Full story

Thursday, July 09, 2015

FDA Strengthens Warning of Heart Attack and Stroke Risk for ...

From NeurologyWire

FDA is strengthening an existing warning in prescription drug labels and over-the-counter (OTC) Drug Facts labels to indicate that nonsteroidal anti-i...Full story

Allergan Buys Rights to Merck's Migraine Drugs

From NeurologyWire

Perhaps the most exciting advance in the migraine pipeline is the development of calcitonin gene-related peptide (CGRP) receptor antagonists, and Alle...Full story

Tuesday, July 07, 2015

Horizon Launches Hostile $3-billion Bid of Depomed

From NeurologyWire

Horizon Pharma said Tuesday it is proposing to acquire all outstanding shares of Depomed at $29.25 per share, in an all-stock deal worth roughly $3 bi...Full story

Epilepsy Increases Risk of Death Among Pregnant Women

From NeurologyWire

New findings suggest that women with epilepsy are at "considerably heightened risk for many adverse outcomes during their delivery hospitalization, in...Full story

Duchenne Muscular Dystrophy Drug Gets FDA Fast Track

From NeurologyWire

FDA has given Fast Track designation to CAT-1004, an agent in development by Catabasis Pharmaceuticals for the treatment of Duchenne muscular dystroph...Full story

Monday, July 06, 2015

Bad Memories Reduced By Video Game Play in New Study

From NeurologyWire

New research shows that even once intrusive memories have been laid down, playing a visually-demanding computer game after reactivating the memories m...Full story

Genes May Not Be to Blame for Link Between Migraine and Hear...

From NeurologyWire

A new study suggests that genes may not be to blame for the increased risk of heart disease some studies have shown in people with migraine, especiall...Full story

Wednesday, July 01, 2015

His and Her Pain Circuitry in The Spinal Cord

From NeurologyWire

New animal research reveals fundamental sex differences in how pain is processed.New research released in Nature Neuroscience reveals for the first ti...Full story

Tuesday, June 30, 2015

Smile and the World Smiles With You, Study Says

From NeurologyWire

Smiling changes the way a person's brains processes other peoples emotions, according to new research published in Social Cognitive and Affective Neur...Full story

Positive Top-line Results For Stroke and TBI Cohorts of Phas...

From NeurologyWire

Avanir Pharmaceuticals released top-line data from the PRISM II study showing that treatment with Nuedexta was associated with a statistically signifi...Full story

New AHA/ASA Guidelines Advocate Stent Retrievers

From NeurologyWire

New guidelines released Monday by the American Heart Association/American Stroke Association offer the organizations' strongest recommendation for mec...Full story